ReviewOncoTargets and therapy2015
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis.
Giovanni Barosi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it